Nancy A. Grygiel - May 2, 2025 Form 4 Insider Report for AMGEN INC (AMGN)

Role
SVP & CCO
Signature
/s/ Nancy A. Grygiel
Stock symbol
AMGN
Transactions as of
May 2, 2025
Transactions value $
-$64,986
Form type
4
Date filed
5/6/2025, 08:13 PM
Previous filing
May 2, 2025
Next filing
May 8, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Grygiel Nancy A. SVP & CCO ONE AMGEN CENTER DRIVE, THOUSAND OAKS /s/ Nancy A. Grygiel 2025-05-02 0001816414

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMGN Common Stock Tax liability -$33.5K -118 -1.46% $283.78 7.98K May 2, 2025 Direct
transaction AMGN Common Stock Tax liability -$31.5K -111 -1.39% $283.78 7.87K May 2, 2025 Direct F1
holding AMGN Common Stock 103 May 2, 2025 401(k) Plan F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares include 67 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F2 These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.